10-Q: Gyrodyne LLC Reports Q3 2024 Results, Net Asset Value Decreases Amidst Entitlement Process and Legal Challenges

Gyrodyne LLC's Q3 2024 report reveals a decrease in net asset value primarily due to a reduction in real estate value and increased liquidation costs, partially offset by proceeds from a rights offering.

Summary

• Gyrodyne LLC's net assets in liquidation decreased to $30.52 million as of September 30, 2024, down from $30.72 million at the end of 2023.
• The decrease is primarily attributed to a $3.48 million reduction in the estimated value of real estate holdings and increased liquidation costs of $1.692 million due to a timeline extension.
• These decreases were partially offset by $4.418 million in net proceeds from a rights offering and other savings of approximately $530,000.
• The estimated liquidation distribution per share decreased to $13.88 from $19.51 due to the reduction in net assets and the issuance of 625,000 new shares at $8 per share.
• The company is pursuing entitlements on its Flowerfield and Cortlandt Manor properties to increase their value before sale.
• The company anticipates the sale of its properties could extend into 2026 due to ongoing legal challenges and regulatory delays.
• Gyrodyne is operating under a liquidation basis of accounting, with the goal of selling all assets, settling debts, and distributing remaining funds to shareholders.
• The company's strategy includes managing its real estate portfolio, pursuing entitlements, and managing capital to maximize shareholder returns.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the decrease in net asset value, the reduction in estimated distributions per share, and the extended timeline for property sales. While the company has taken positive steps such as the rights offering and pursuing entitlements, the ongoing legal challenges and market uncertainties create a cautious outlook.

Positives

• The company successfully completed a rights offering, raising $4.4 million in net proceeds.
• Gyrodyne is actively pursuing entitlements to increase the value of its properties.
• The company is marketing its properties through JLL Capital Markets.
• The company is managing its billing and collection process internally to minimize losses from defaults.
• The company has a zero balance in its allowance for doubtful accounts.
• The Supreme Court of the State of New York issued a ruling in favor of the Company dismissing the Article 78 petition in its entirety.

Negatives

• The net asset value decreased by $200,762 due to a reduction in real estate value and increased liquidation costs.
• The estimated liquidation distribution per share decreased from $19.51 to $13.88.
• The timeline for property sales has been extended to 2026 due to legal challenges and regulatory delays.
• The company is facing an ongoing Article 78 Proceeding, which could take up to two years or more to resolve.
• The company has incurred significant land entitlement costs of $318,000 during the nine months ended September 30, 2024.
• The company has a loan payable of $477,829 with interest accruing at 0.75% per month through 2024 and 1.0% per month starting January 2025.

Risks

• The Article 78 Proceeding could take up to two years or more to resolve, potentially delaying property sales.
• The company's ability to obtain required permits and authorizations is subject to factors beyond its control, including environmental concerns.
• The company's estimates of costs and values may differ from actual results due to the inherent uncertainty of the liquidation process.
• The company is exposed to risks related to the real estate markets of Suffolk and Westchester Counties in New York.
• The company is subject to the potential residual effects of the COVID-19 pandemic, ongoing inflation risk, and interest rate uncertainty.
• The company's tenants in the healthcare industry are subject to substantial regulation and cost control measures.
• The company's leases may not renew for the same square footage or at favorable rates.
• The company's regional concentration in tenants will increase credit risk from exposure of the local economies.

Future Outlook

Gyrodyne anticipates that the process of negotiating purchase agreements, securing final subdivision approval, and consummating the sale of its properties could extend into 2026. The company intends to aggressively market its properties and negotiate contracts to complete the process as soon as practicable, but the timeline is largely dependent on factors outside the company's control.

Management Comments

• Gyrodyne's corporate strategy is to pursue entitlements on our two remaining properties, so that they can be sold to one or more developers with increased development flexibility at higher prices, thereby maximizing value and distributions.
• Gyrodyne intends to dissolve after we complete the disposition of our assets, apply the proceeds to settle debts and claims, and then pay liquidating distributions to our shareholders.
• Gyrodyne remains confident in its defense of the appeal and the motion to renew and reargue in the Article 78 Proceeding.
• The Company believes the process of negotiating purchase agreements, securing final approvals and consummating the sale of our properties will culminate in 2026.

Industry Context

The report highlights the challenges faced by real estate companies in the current economic climate, including the impact of the COVID-19 pandemic, inflation, and rising interest rates. The shift towards remote working and telemedicine has also impacted demand for office and medical office space. The company's focus on obtaining entitlements to increase property value is a common strategy in the real estate development industry.

Comparison to Industry Standards

• Gyrodyne's strategy of pursuing entitlements to increase property value is a common practice among real estate developers, similar to companies like Howard Hughes Corporation which focuses on master-planned communities.
• The company's liquidation approach is similar to that of companies undergoing restructuring or asset sales, such as Sears Holdings, which sold off assets to maximize value for creditors and shareholders.
• The legal challenges faced by Gyrodyne are not uncommon in the real estate development sector, where zoning and environmental regulations often lead to disputes, similar to the challenges faced by projects like the Dakota Access Pipeline.
• The company's reliance on third-party appraisals and market data for valuation is consistent with industry standards, similar to how REITs like Simon Property Group value their real estate portfolios.
• The company's use of discounted cash flow models for valuation is a standard practice in real estate, similar to the methods used by companies like Brookfield Asset Management.

Legal Proceedings

• The company is involved in an ongoing Article 78 Proceeding related to the Flowerfield subdivision application.
• The company is also subject to a Stipulation of Settlement from a previous class action lawsuit, which requires sales to be at or above 2014 appraised values.

Related Party Transactions

• The company has a leasing arrangement with a not-for-profit organization where the company's Chairman serves as Chairman and a director, with a below-market lease of $8,829 annually and $44,144 during the extended period.

Stakeholder Impact

• Shareholders are impacted by the decrease in net asset value and the reduction in estimated distributions per share.
• Employees are impacted by the retention bonus plan and potential severance commitments.
• Tenants are impacted by the company's efforts to manage and enhance the value of its properties.
• Creditors are impacted by the company's debt obligations and the liquidation process.

Next Steps

• The company will continue to pursue entitlements on its Flowerfield and Cortlandt Manor properties.
• The company will continue to market its properties through JLL Capital Markets.
• The company will defend against the appeal and motion to renew and reargue in the Article 78 Proceeding.
• The company will negotiate purchase agreements for its properties.
• The company will seek final subdivision and site plan approvals.

Key Dates

Keywords

real estate, liquidation, entitlements, property development, land subdivision, medical office, industrial park, legal proceedings, rights offering, net asset value